Reemplazo hepático extracorpóreo no biológico: tipos e indicaciones
Barra lateral del artículo
Contenido principal del artículo
Resumen
.
##plugins.themes.bootstrap3.displayStats.downloads##
Detalles del artículo
Sección
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Cómo citar
Referencias
Rosa Diez g., gadano a. Reemplazo hepático extracorpóreo. en: Do Pico Jl, greloni g, giannasi se , et al. nefrología crítica. Buenos aires: Journal; 2009. p. 512-9.
cameron s. Breve historia de la hemodiálisis (1850-1970): hombres, materiales e ideas. en: Jofré R, lópez gómez JM, luño J, et al. tratado de hemodiálisis. Madrid: Jims; 2006. p. 1-37.
Davenport a. continuous renal replacement therapy for liver disease. Hemodial int. 2003;7(4):348-52.
sen s, Williams R, Jalan R. emerging indications for albumin dialysis. am J gastroenterol. 2005;100(2):468-75
Mitzner sR, stange J, Klammt s, et al. improvement of hepatorenal syndrome with extracorporeal albumin dialysis MaRs : results of a prospective, randomized, controlled clinical trial. liver transpl. 2000;6(3):277-86.
Heemann u, treichel u, loock J, et al. albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology. 2002;36(4 Pt 1):949-58.
Kreymann B, seige M, schweigart u, et al. albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol. 1999;31(6):1080-5
Chawla ls , georgescu F, abell B, et al. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin. am J Kidney Dis. 2005;45(3):e51-6.
Rosa Diez g, greloni g, gadano a, et al. combined extended haemodialysis with single-pass albumin dialysis (sPae D). nephrol Dial transplant. 2007;22(9):2731-2.
sauer iM, goetz M, steffen i, et al. in vitro comparison of the molecular adsorbent recirculation system (MaRs) and single-pass albumin dialysis (sPaD). Hepatology. 2004;39(5):1408-14.
Peszynski P, Klammt s, Peters e, et al. albumin dialysis: single pass vs. recirculation (MaRs). liver. 2002;22 suppl 2:40-2.
Kramer l, Bauer e, schenk P, et al. successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPsa -Prometheus). Wien Klin Wochenschr. 2003;115(15-16):599-603.
Rifai K, ernst t, Kretschmer u, et al. Prometheus-a new extracorporeal system for the treatment of liver failure. J Hepatol. 2003;39(6):984-90.
evenepoel P, laleman W, Wilmer a, et al. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. artif Organs. 2006;30(4):276-84.
Krisper P, Haditsch B, stauber R, et al. in vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol. 2005;43(3):451-7.
stadlbauer v, Krisper P, Beuers u, et al. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure. asai O J. 2007;53(2):187-93.
Krisper P, stauber Re. technology insight: artificial extracorporeal liver support--how does Prometheus compare with MaRs? nat clin Pract nephrol. 2007;3(5):267-76.
Rifai K, Kribben a, gerken g, et al. extracorporeal liver support by fractionated plasma separation and adsorption (PROMet Heus ®) in patients with acute-onchronic liver failure (Heli Os study): a prospective randomized controlled multicenter study. J Hepatol 2010;52 suppl 1:s3.
steiner c, Mitzner s. experiences with MaRs liver support therapy in liver failure: analysis of 176 patients of the international MaRs Registry. liver. 2002;22 suppl 2:20-5.
grodzicki M, Kotulski M, leonowicz D, et al. Results of treatment of acute liver failure patients with use of the Prometheus FPsa system. transplant Proc. 2009;41(8):3079-81
Rifai K, Manns MP. Review article: clinical experience with Prometheus. ther apher Dial. 2006;10(2):132-7.
Jalan R, sen s, steiner c, et al. extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol. 2003;38(1):24-31.
Doria c, Mandalá l, smith J, et al. effect of molecular adsorbent recirculating system in hepatitis c virus-related intractable pruritus. liver transpl. 2003;9(4):437-43.
Rifai K, Hafer c, Rosenau J, et al. treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus). scand J gastroenterol. 2006;41(10):1212-7.
Kellersmann R, gassel HJ, Bühler c, et al. application of Molecular adsorbent Recirculating system in patients with severe liver failure after hepatic resection or transplantation: initial single-centre experiences. liver. 2002;22 suppl 2:56-8.
Mullhaupt B, Kullak-ublick ga , ambühl P, et al. First clinical experience with Molecular adsorbent Recirculating system (MaRs) in six patients with severe acute on chronic liver failure. liver. 2002;22 suppl 2:59-62